多囊卵巢中卵母细胞分泌因子GDF9与BMP15的卵泡内浓度呈反向变化
研究比较了多囊卵巢(PCO)与非PCO女性小窦卵泡液中GDF9、BMP15及GDF9/BMP15异二聚体浓度。PCO女性GDF9显著升高而BMP15较低,GDF9:BMP15比值显著升高,且BMP15与AMH等关联在PCO女性中由正转负。作者认为GDF9:BMP15比值可能成为PCO的新生物标志物。
要点
- PCO女性卵泡液GDF9显著高于非PCO女性,BMP15则较低。
- PCO女性GDF9:BMP15比值显著高于非PCO女性。
- BMP15与AMH等关联在非PCO女性为正,在PCO女性转为负。
核心结论
- PCO女性卵泡内GDF9与BMP15浓度呈反向变化,反映内分泌环境异常;GDF9:BMP15比值升高可能成为PCO的新生物标志物。
研究设计与样本
- 收集87名因生育力保存接受卵巢组织冷冻女性的未刺激卵巢中4至11毫米卵泡的卵泡液共356份。
- 识别出27名PCO女性,并按年龄和卵泡大小匹配60名非PCO女性。
- 采用酶联免疫吸附试验测定GDF9、BMP15、GDF9/BMP15异二聚体、AMH、抑制素A和B、总抑制素、激活素B和AB及卵泡抑素浓度。
主要发现
- GDF9、BMP15和GDF9/BMP15异二聚体可检测率分别为100%、94.4%和91.5%,浓度随卵泡增大显著负相关(P < 0.0001)。
- PCO女性GDF9显著高于非PCO女性(PCO:4230 ± 189 pg/mL,n = 188;非PCO:3498 ± 199 pg/mL,n = 168;P < 0.03)。
- PCO女性BMP15低于非PCO女性(PCO:431 ± 40 pg/mL,n = 125;非PCO:573 ± 55 pg/mL,n = 109;P = 0.10)。
- PCO女性GDF9:BMP15比值显著高于非PCO女性(P < 0.01)。
- 非PCO女性中BMP15与AMH、激活素及抑制素呈显著正相关,在PCO女性中转为负相关。
关键数值与推荐
- PCO女性GDF9为4230 ± 189 pg/mL(n = 188),非PCO女性为3498 ± 199 pg/mL(n = 168),P < 0.03。
- PCO女性BMP15为431 ± 40 pg/mL(n = 125),非PCO女性为573 ± 55 pg/mL(n = 109),P = 0.10。
- GDF9:BMP15比值在PCO女性中显著高于非PCO女性,P < 0.01。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The oocyte-secreted factors growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) play essential roles in follicle development and oocyte maturation, and aberrant regulation might contribute to the pathogenesis of polycystic ovary syndrome. OBJECTIVE: Are there measurable differences in concentrations of GDF9, BMP15, and the GDF9/BMP15 heterodimer in small antral follicle fluids from women with and without polycystic ovaries (PCO)? DESIGN AND SETTING: Follicle fluids (n = 356) were collected from 4- to 11-mm follicles in unstimulated ovaries of 87 women undergoing ovarian tissue cryopreservation for fertility preservation. PATIENTS: Twenty-seven women with PCO were identified and 60 women without PCO-like characteristics (non-PCO women) were matched according to age and follicle size. MAIN OUTCOME MEASURES: Intrafollicular concentrations of GDF9, BMP15, GDF9/BMP15 heterodimer, anti-Mullerian hormone (AMH), inhibin-A and -B, total inhibin, activin-B and -AB, and follistatin were measured using enzyme-linked immunosorbent assays. RESULTS: The detectability of GDF9, BMP15, and the GDF9/BMP15 heterodimer were 100%, 94.4%, and 91.5%, respectively, and concentrations were significantly negatively correlated with increasing follicle size (P < 0.0001). GDF9 was significantly higher in women with PCO (PCO: 4230 ± 189 pg/mL [mean ± SEM], n = 188; non-PCO: 3498 ± 199 pg/mL, n = 168; P < 0.03), whereas BMP15 was lower in women with PCO (PCO: 431 ± 40 pg/mL, n = 125; non-PCO: 573 ± 55 pg/mL, n = 109; P = 0.10), leading to a significantly higher GDF9:BMP15 ratio in women with PCO (P < 0.01). Significant positive associations between BMP15 and AMH, activins, and inhibins in non-PCO women switched to negative associations in women with PCO. CONCLUSIONS: Intrafollicular concentrations of GDF9 and BMP15 varied inversely in women with PCO reflecting an aberrant endocrine environment. An increased GDF9:BMP15 ratio may be a new biomarker for PCO.
引用
- Kristensen SG, Kumar A, Mamsen LS, et al. Intrafollicular Concentrations of the Oocyte-secreted Factors GDF9 and BMP15 Vary Inversely in Polycystic Ovaries. J Clin Endocrinol Metab. 2022. PMID: 35511085. doi:10.1210/clinem/dgac272
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。